Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| BCAP-XHEALTH | SCBGENOME(A) | |
|---|---|---|
| Held by both | ||
| 1.92% | 10.03% | |
| 1.87% | 8.02% | |
| 1.66% | 7.15% | |
| Only in BCAP-XHEALTH | ||
| 2.03% | N/A | |
| 1.62% | N/A | |
| 1.37% | N/A | |
| 1.33% | N/A | |
| Only in SCBGENOME(A) | ||
| N/A | 4.20% | |
| N/A | 4.05% | |
| Personalis | N/A | 3.91% |
| N/A | 3.69% | |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(A) | +65.00% | 42.55% | 1.53 |
| BCAP-XHEALTH | +19.45% | 19.53% | 1.00 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | BCAP-XHEALTH | SCBGENOME(A) |
|---|---|---|
Fund details | ||
| Fund size | 467 million | 261 million |
| Inception date | 14 May 2021 | 20 Aug 2021 |
| Master fund | กองทุนที่ลงทุนหลายกอง | กองทุน ARK Genomic Revolution ETF |
| Dividend policy | Does not pay | Does not pay |
Risk and currency hedging | ||
| Risk level | 6 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 57.68% |
Minimum purchase and redemption | ||
| First purchase | 500 THB | 1,000 THB |
| Subsequent purchase | 500 THB | 1,000 THB |
| Redemption (amount) | No minimum | 1,000 THB |
| Redemption (units) | No minimum | No minimum |
| Balance (amount) | No minimum | 1,000 THB |
| Balance (units) | No minimum | No minimum |
Order cut-off and redemption payment | ||
| Buy before | 15:30 | 15:30 |
| Redeem before | 15:30 | 15:30 |
| Redemption paid | T+3 | T+4 |